0 items USD 0.00Search
- Did you mean
- rejuvenation idiopathic arthrex
Your search for "Juvenile idiopathic arthritis" gave back 2785 results.
Etanercept is a medication used to manage and treat autoimmune conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis,...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H2 2019 Summary Toll Like Receptor 8 (CD288 or TLR8) pipeline Target constitutes close to 22...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
The global Enbrel (Etanercept) Biosimilar market size is projected to grow from US$ 1219.9 million in 2022 to US$ 1688.2 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Adalimumab, sold under the trade name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
GIR
April 2023
Price: USD 3,480.00
The biologics used in Anti-inflammatory treatment – abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), etanercept (Enbrel), infliximab (...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H1 2018 Summary Tyrosine Protein Kinase JAK1 (Janus Kinase 1...
Catalog:
Global Markets Direct
May 2018
Price: USD 3,500.00
The global Humira market size was valued at USD 17560 million in 2023 and is forecast to a readjusted size of USD 9840.6 million by 2030 with a CAGR...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Adalimumab, sold under the brand name Humira, among others, is a monoclonal antibody used to treat rheumatoid arthritis, psoriatic arthritis,...
Catalog:
MRRPB5
April 2024
Price: USD 2,900.00
The biologics used in Anti-inflammatory treatment – abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), etanercept (Enbrel), infliximab (...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H2 2018 Summary According to the recently published report...
Catalog:
Global Markets Direct
November 2018
Price: USD 3,500.00
The global Enbrel (Etanercept) and Biosimilar market size is projected to grow from US$ 6211.9 million in 2022 to US$ 7862.4 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Interleukin 1 Receptor Type 1 - Pipeline Review, H2 2019 Summary Interleukin 1 Receptor Type 1 (CD121 Antigen Like Family Member A or Interleukin 1...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Juvenile Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021 Summary Juvenile Rheumatoid Arthritis (Immunology) - Drugs in Development,...
Catalog:
Global Markets Direct
April 2021
Price: USD 2,000.00
Juvenile Rheumatoid Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Juvenile Rheumatoid Arthritis...
Catalog:
Global Markets Direct
May 2022
Price: USD 2,000.00
